Use of RAAS blockers in patients with malignant hypertension and thrombotic microangiopathy: A series of clinical observations
Malignant arterial hypertension (MAH) is a medical emergency characterized by severe elevation of blood pressure (BP; typically, >180/120 mmHg) accompanied by acute target-organ damage involving the kidneys, central nervous system, eyes, and/or heart. The severity and duration of arterial hypertension are important det...